Publisher’s Window
I have been following the problem pharmacies are having with DIR (direct and indirect reimbursement). This is nothing more than a rip-off of pharmacies by the PBMs, and clawing back a portion of the patient’s co-pay is something I find an egregious act on the part of PBMs to profit at the expense of the consumer. Moreover, to leave pharmacies up in the air on the adjusted reimbursement they are going to receive is something that makes managing receivables a nightmare.